0.6452.38% ( +0.015 )
Delay Closed: Nov 17, 16:08:15Shareholders
All Shareholders
Shareholder Type
- Public and others56.22%
- VC/PE firms28.43%
- Individuals & Insiders12.65%
- Institutions2.69%
Major Shareholders
| Shareholder | |||||
|---|---|---|---|---|---|
Eli Lilly Investment Consulting (Shanghai) Co., Ltd. | 16.52% | 70.54M | 0.03% | +0 | |
Xueming QianExecutive Chairman & CEO | 12.30% | 52.52M | 0.09% | +370.00K | |
Temasek Holdings (Private) Limited | 6.58% | 28.09M | 0.01% | +0 | |
Chengtong Fund Management Co., Ltd. | 5.33% | 22.78M | 1.33% | -5.69M | |
China Merchants Kunlun Capital Co., Ltd. | 2.57% | 10.95M | <0.01% | +0 | |
Li XuHead of CDx, Member of Scientific Advisory Board, Strategic Advisor to CEO & Non-Executive Director | 0.32% | 1.35M | <0.01% | +10.00K | |
Dimensional Fund Advisors LP | 0.13% | 542.00K | 0.03% | -123.50K | |
Jiasong TangIndependent Non-Executive Director | <0.01% | 40.00K | <0.01% | +10.00K | |
Zhihua ZhangFormer Independent Non-Executive Director | <0.01% | 40.00K | <0.01% | +10.00K | |
Kumar SrinivasanFormer Independent Non-Executive Director | <0.01% | 30.00K | <0.01% | +10.00K | |
Wei ChenIndependent Non-Executive Director | <0.01% | 20.00K | <0.01% | +0 |
